Interaction atlas / 2026 edition

What interacts with DXM?

Find a substance to learn about the hazards of combining it with dextromethorphan (DXM) and the supporting evidence.

Or choose a substance group

PHI is a provisional hazard rating for a combination with DXM on a 0–10 scale.

MAO inhibitors More about this group
Antidepressants

Also belongs to this group

More about this group
Stimulants More about this group
Opioids and opioid-like agents More about this group
Other depressants More about this group
Dissociatives More about this group
Psychedelics More about this group
Cannabinoids More about this group
Antihistamines and antiemetics More about this group
Other metabolic modifiers More about this group
Other agents and products — Lithium, St John’s wort, 5-HTP
  • No PHI rating
    Why is there no PHI rating?

    The review leaves PHI unassigned for DXM with 5-HTP because data for a numerical comparison are insufficient.

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

  • No PHI rating
    Why is there no PHI rating?

    The review gives this DXM combination no PHI. Mirtazapine, buspirone, triptans and cyclobenzaprine differ in pharmacology and main concerns.

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

  • No PHI rating
    Why is there no PHI rating?

    A combination medicine contains DXM and other active ingredients. Acetaminophen, chlorphenamine, sedating antihistamines and sympathomimetic decongestants can cause their own toxic effects as more of the product is taken. Most cards assess DXM with one other substance; a combination medicine requires accounting for all its ingredients [6, 7, 25]. Extended release also changes how long the substances act together.

    Full explanation from the review

    DXM alone must be distinguished from combination medicines. Acetaminophen (paracetamol), chlorphenamine, sedating antihistamines, and sympathomimetic decongestants can create their own toxicity when more of the product is taken. These ingredients place the product outside most two-substance rows [6, 7, 25]. Extended-release formulations also alter the duration of overlapping effects.

  • No PHI rating
    Why is there no PHI rating?

    The review gives this DXM combination no PHI. Mirtazapine, buspirone, triptans and cyclobenzaprine differ in pharmacology and main concerns.

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

  • No PHI rating
    Why is there no PHI rating?

    Alkaloid concentrations in Datura and Atropa belladonna vary, so the amount of plant material does not reliably indicate the amount of active substances. The review excludes these plants from numerical PHI scoring because that scoring assumes a known exposure to the active substance [35].

    Full explanation from the review

    Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44]. Datura and Atropa belladonna are excluded because variable alkaloid concentrations undermine the known-exposure assumption [35]. Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31]. Their concerns are discussed in Sections 5 and 8.

  • No PHI rating
    Why is there no PHI rating?

    The review leaves PHI unassigned for DXM with lithium because data for a numerical comparison are insufficient.

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

  • No PHI rating
    Why is there no PHI rating?

    Piracetam, DMAE, and lecithin are excluded from the numerical matrix. The FAQ contains accounts of subjective memory improvement, but evidence is insufficient to treat them as protection against physical injury.

  • No PHI rating
    Why is there no PHI rating?

    Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31].

    Full explanation from the review

    Selegiline, rasagiline, and safinamide with maintained MAO-B selectivity are excluded from numerical ranking. Contraindications remain relevant, but evidence is insufficient to quantify physiological concern under that specific condition [26, 34, 44]. Datura and Atropa belladonna are excluded because variable alkaloid concentrations undermine the known-exposure assumption [35]. Ondansetron is excluded because of its disputed serotonergic mechanism and insufficient assessment of the pure pair; QT-prolonging drugs are excluded as a class because mechanisms and conditions vary [4, 30, 31]. Their concerns are discussed in Sections 5 and 8.

  • No PHI rating
    Why is there no PHI rating?

    The review leaves PHI unassigned for DXM with St John’s wort because data for a numerical comparison are insufficient. ACMT lists St John’s wort as a possible interacting agent, without a numerical estimate for this pair [25].

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

  • No PHI rating
    Why is there no PHI rating?

    Triptans differ in pharmacology; the review leaves PHI unassigned for their DXM combinations. ACMT lists triptans as possible interacting agents, without numerical estimates for individual pairs [25].

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

  • No PHI rating
    Why is there no PHI rating?

    The review leaves PHI unassigned for DXM with tryptophan because data for a numerical comparison are insufficient.

    Full explanation from the review

    Lithium, St John’s wort, 5-HTP and tryptophan have no PHI in the review because data for a numerical comparison are limited: their pharmacology, product composition and conditions of use differ. Mirtazapine, buspirone, triptans and cyclobenzaprine also differ in mechanisms and physiological hazards. The review gives this list no shared PHI range. ACMT lists triptans and St John’s wort as possible interacting agents; its warning lists substances without numerical estimates for individual pairs [25]. The absence of PHI reflects limited grounds for a comparative number.

More about this group

The US label for Robitussin Long-Acting CoughGels lists dextromethorphan hydrobromide (DXM). For “Robitussin DM CoughGels”, check the exact product name and active ingredients on its label.

Find combinations by mechanism

Choose a mechanism to see all combinations linked to it.

Map and table by substance group
Connection map

Substance groups and mechanisms

70 PHI-rated entries

Each marker counts family entries with group tags.

List: exact links and counts

MAO inhibitors · 7

Antidepressants · 7

Stimulants · 10

Opioids and opioid-like agents · 9

Other depressants · 9

Dissociatives · 5

Psychedelics · 8

Cannabinoids · 2

Antihistamines and antiemetics · 7

Other metabolic modifiers · 6

Highlighted lines show structured links; dashed lines have only uncertain tags. PHI ratings are given in the combination entries.

No PHI rating · 14

Combinations by mechanism

Choose a category to see PHI-rated combinations. The numbers show how many combinations are in each list.

How to read the table

0 means the category is not marked in the review. ? N means the mechanism’s contribution is uncertain for N combinations. A combination may appear in several columns; it is counted once in the overall total.

Combinations by mechanism
Substance groups Sero­tonin-related Cardio­vascular and thermal Sedation and respi­ration Metab­olism NMDA Anti­musca­rinic Seizure-related concern Other discussed pathways
MAO inhibitors 7 entries 7 This category is not marked in the review This category is not marked in the review 1 This category is not marked in the review This category is not marked in the review This category is not marked in the review This category is not marked in the review
Antidepressants 7 entries 7 3 1 3 This category is not marked in the review 1 This category is not marked in the review This category is not marked in the review
Stimulants 10 entries 5 The mechanism’s contribution is uncertain for 1 combination 10 This category is not marked in the review 1 This category is not marked in the review This category is not marked in the review This category is not marked in the review This category is not marked in the review
Opioids and opioid-like agents 9 entries 5 The mechanism’s contribution is uncertain for 1 combination 2 9 3 The mechanism’s contribution is uncertain for 1 combination This category is not marked in the review This category is not marked in the review 2 This category is not marked in the review
Other depressants 9 entries This category is not marked in the review This category is not marked in the review 9 This category is not marked in the review This category is not marked in the review This category is not marked in the review This category is not marked in the review This category is not marked in the review
Dissociatives 5 entries This category is not marked in the review 2 1 This category is not marked in the review 5 This category is not marked in the review This category is not marked in the review 2 The mechanism’s contribution is uncertain for 1 combination
Psychedelics 8 entries 7 5 1 This category is not marked in the review This category is not marked in the review This category is not marked in the review 1 1
Cannabinoids 2 entries This category is not marked in the review 1 This category is not marked in the review 1 This category is not marked in the review This category is not marked in the review This category is not marked in the review 2
Antihistamines and antiemetics 7 entries 1 This category is not marked in the review 6 The mechanism’s contribution is uncertain for 1 combination 1 The mechanism’s contribution is uncertain for 1 combination This category is not marked in the review 5 This category is not marked in the review This category is not marked in the review
Other metabolic modifiers 6 entries This category is not marked in the review 1 This category is not marked in the review 6 This category is not marked in the review This category is not marked in the review 1 This category is not marked in the review
Total rated entries 32 entries 24 entries 27 entries 16 entries 5 entries 6 entries 4 entries 5 entries
MAO inhibitors: 7 entries

MAO inhibitors

Antidepressants: 7 entries

Antidepressants

Stimulants: 10 entries

Stimulants

Opioids and opioid-like agents: 9 entries

Opioids and opioid-like agents

Other depressants: 9 entries

Other depressants

Dissociatives: 5 entries

Dissociatives

Psychedelics: 8 entries

Psychedelics

Cannabinoids: 2 entries

Cannabinoids

Antihistamines and antiemetics: 7 entries

Antihistamines and antiemetics

Other metabolic modifiers: 6 entries

Other metabolic modifiers

Total rated entries
  • Serotonin-related: 32 entries
  • Cardiovascular and thermal: 24 entries
  • Sedation and respiration: 27 entries
  • Metabolism: 16 entries
  • NMDA: 5 entries
  • Antimuscarinic: 6 entries
  • Seizure-related concern: 4 entries
  • Other discussed pathways: 5 entries

Total: 70 rated entries

Entry count
  1. 0
  2. 5
  3. 10

Expand a substance group to see its coloured counts.

Total: 70 rated entries

Entries without a PHI rating: 14
01 / PHI · M · D

How to read PHI

PHI is a provisional hazard rating for a combination with DXM on a 0–10 scale.

Overlapping ranges: the ordering by hazard level remains uncertain

Method →

Understand differences

Stories and diagrams with conditions, sources and limits.

Learn → Compare two combinations →
1997 → 2026

FAQ update

29 claims · 10 topics. A selective audit of the historical FAQ.

Archive & laboratory →
Reference

Open the source and related combinations →